Overexpression of CDK2 is a prognostic indicator of oral cancer progression
- PMID: 11267947
- PMCID: PMC5926707
- DOI: 10.1111/j.1349-7006.2001.tb01102.x
Overexpression of CDK2 is a prognostic indicator of oral cancer progression
Abstract
Cyclins and cyclin-dependent kinases (CDKs) play key roles in cell cycle regulation, a process of which dysregulation can lead to uncontrolled cell growth and hence to cancer. We have already reported the alteration of CDK4 and cyclin D1 expression in oral cancer. In this study, we examined by immunohistochemistry the expression of CDK2, and cyclins A and E in 20 normal oral mucosa, 42 dysplastic epithelia, and 103 oral squamous cell carcinomas (SCCs). The expressions of CDK2, and cyclins A and E were not detected in the normal epithelium and significantly altered from epithelial dysplasia to SCC. While there were no significant correlations between the expression of cyclins A, E and the patients' survival, CDK2 expression was significantly correlated with lymph node involvement (P = 0.025), tumor differentiation (P = 0.032), mode of tumor invasion (P = 0.017), and shorter survival period (P = 0.0173). These results suggest that the elevated expression of CDK2 is a critical factor in oral cancer progression and can be used as a negative predictive marker of the patients' prognosis.
Similar articles
-
Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma.Clin Cancer Res. 2001 Sep;7(9):2776-82. Clin Cancer Res. 2001. PMID: 11555592
-
Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma.Anticancer Res. 1998 May-Jun;18(3A):1661-4. Anticancer Res. 1998. PMID: 9673386
-
Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas.J Pathol. 2003 Feb;199(2):208-20. doi: 10.1002/path.1247. J Pathol. 2003. PMID: 12533834
-
Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.Br J Cancer. 1999 Apr;80(1-2):256-61. doi: 10.1038/sj.bjc.6690348. Br J Cancer. 1999. PMID: 10390005 Free PMC article.
-
Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity.Oral Oncol. 2002 Apr;38(3):235-43. doi: 10.1016/s1368-8375(01)00048-3. Oral Oncol. 2002. PMID: 11978545
Cited by
-
Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression.Onco Targets Ther. 2013;6:199-209. doi: 10.2147/OTT.S37407. Epub 2013 Mar 22. Onco Targets Ther. 2013. PMID: 23569384 Free PMC article.
-
Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region.Med Oncol. 2006;23(1):1-15. doi: 10.1385/MO:23:1:1. Med Oncol. 2006. PMID: 16645225 Review.
-
The CDK inhibitors in cancer research and therapy.J Cancer Res Clin Oncol. 2011 Oct;137(10):1409-18. doi: 10.1007/s00432-011-1039-4. Epub 2011 Aug 30. J Cancer Res Clin Oncol. 2011. PMID: 21877198 Review.
-
Low Expression of CDK10 Correlates with Adverse Prognosis in Gastric Carcinoma.J Cancer. 2017 Aug 25;8(15):2907-2914. doi: 10.7150/jca.20142. eCollection 2017. J Cancer. 2017. PMID: 28928881 Free PMC article.
-
Salivary biomarkers in non-invasive oral cancer diagnostics: a comprehensive review.J Appl Oral Sci. 2024 Sep 9;32:e20240151. doi: 10.1590/1678-7757-2024-0151. eCollection 2024. J Appl Oral Sci. 2024. PMID: 39258715 Free PMC article. Review.
References
-
- Pardee , A. B.G1 events and regulation of cell proliferation . Science , 24 , 603 – 608 ( 1989. ). - PubMed
-
- Lee , E. , Faha , B. , Dulic , V. , Reed , S. I. . and Harlow , E.Cyclin E/CDK2 and cyclin A/CDK2 kinase associated with p107, and E2F in a temporally distinct manner . Genes Dev. , 6 , 1874 – 1875 ( 1992. ). - PubMed
-
- Xiong , Y. , Connolly , T. , Futcher , B. . and Beach , D.Human D‐type cyclin . Cell , 65 , 691 – 699 ( 1991. ). - PubMed
-
- Sherr , C. J.G1 phase progression: cyclin on cue . Cell , 79 , 551 – 555 ( 1994. ). - PubMed
-
- Hunter , T. . and Pines , J.Cyclin D and CDK inhibitors come of age . Cell , 79 , 573 – 582 ( 1994. ). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials